Fundraising Fox
Shankar Balasubramanian
InvestorFounding Partner at Ahren Innovation Capital
United Kingdom
Writes $100K – $5M checks · typically $1.5M
Find your path to Shankar
Sign up to see every warm intro you have to Shankar
- Paths you didn't know you had: your email and LinkedIn already hold routes to Shankar. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Founding Partner and principal inventor of the next-generation sequencing technology used in Illumina platforms. Professor of Medicinal Chemistry at Cambridge and a Fellow of the Royal Society; winner of the 2022 Breakthrough Prize.
Invests in
AI & Machine LearningBiotechClimate TechDeep TechHardwareRobotics
Deals · 1
Cambridge EpigenetixBoard seat
via Ahren Innovation Capital · filed May 2018 · $12.3M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Ahren Innovation Capital
Frequently asked questions
- Who is Shankar Balasubramanian?
- Founding Partner and principal inventor of the next-generation sequencing technology used in Illumina platforms. Professor of Medicinal Chemistry at Cambridge and a Fellow of the Royal Society; winner of the 2022 Breakthrough Prize.
- Where does Shankar Balasubramanian work?
- Shankar Balasubramanian is Founding Partner at Ahren Innovation Capital.
- What does Shankar Balasubramanian invest in?
- Shankar Balasubramanian invests in AI & Machine Learning, Biotech, Climate Tech, Deep Tech, Hardware, Robotics.
- What check size does Shankar Balasubramanian write?
- Shankar Balasubramanian typically writes checks of $100K – $5M.
- What boards does Shankar Balasubramanian sit on?
- Shankar Balasubramanian holds tracked board seats at Cambridge Epigenetix.
About this profile. Compiled from public sources — Ahren Innovation Capital's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights